Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy

• Status: Recruiting
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez & Tulandi, 2017). A variety of medical and surgical treatment modalities for CSP have been reported; however, most of these are based on low-level evidence(Sun et al., 2019).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Methotrexate

Criteria

Inclusion Criteria:•

• Gestational age before 13 w

• Past history of 1 or more CS

• Presence of GS implanted on cesareans scar

Exclusion Criteria:

• Presence of severe vaginal bleeding (emergency)

• Previous history of uterine surgery other than CS

• The whole mass is interior and the bulge is more in the cavity

• Bleeding disorder

• Patient not candidate for methotrexate (Positive fetal heart pulsation,

• Patient refuse to participate in the study